6,19-Sulfur-bridged progesterone analogues with antiimmunosuppressive activity

Journal of Medicinal Chemistry

Volumn 48, Issue 18, 2005, Pages 5675-5683

  Veleiro, Adriana S ^a   Pecci, Adali ^a   Monteserín, María C ^a   Baggio, Ricardo ^c   Garland, María T ^b   Lantos, Carlos P ^a   Burton, Gerardo ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b DEPARTAMENTO DE FÍSICA   (Chile)

^c DEPARTAMENTO DE FÍSICA   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

19 SULFANYLPREGN 5 ENE; 21 HYDROXY 6,19 EPITHIOPROGESTERONE; 21 HYDROXY 6,19 EPITHIOPROGESTERONE S,S DIOXIDE; 6,19 EPITHIOPROGESTERONE; DEXAMETHASONE; FLUORESCEIN ISOTHIOCYANATE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOCORTIN 5; PROGESTERONE DERIVATIVE; SULFUR DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIIMMUNOSUPPRESSIVE ACTIVITY; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYCLIZATION; DRUG ACTIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME INHIBITION; HELA CELL; HUMAN; HUMAN CELL; IODINATION; NONHUMAN; PARAMETER; RAT; STRUCTURE ANALYSIS; THYMOCYTE;

ANIMALS; APOPTOSIS; CERCOPITHECUS AETHIOPS; COS CELLS; DESOXYCORTICOSTERONE; DEXAMETHASONE; GLUCOCORTICOIDS; HELA CELLS; HUMANS; IMMUNE TOLERANCE; MALE; MICE; MOLECULAR CONFORMATION; MOLECULAR STRUCTURE; NF-KAPPA B; PROGESTERONE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, PROGESTERONE; STEREOISOMERISM; STRUCTURE-ACTIVITY RELATIONSHIP; SULFIDES; THYMUS GLAND; TUMOR NECROSIS FACTOR-ALPHA;

EID: 24744441919     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm049266x     Document Type: Article

References (37)

1. A preliminary report of part of this work is described in Burton, G.; Lantos, C. P.; Veleiro, A. S. EP 1330468, 2003.
2. Tuckermann, J. P.; Kleiman, A.; McPherson, K. G.; Reichardt, H. M. Molecular mechanisms of glucocorticoids in the control of inflammation and lymphocyte apoptosis. Crit. Rev. Cl. Lab. Sci. 2005, 42, 71-104.
3. Weeks, C. M.; Duax, W. L.; Wolff, M. E. Comparison of the molecular structure of six corticosteroids. J. Am. Chem. Soc. 1973, 95, 2865-2868.
4. Burton, G.; Galigniana, M. D.; de Lavallaz, S.; Brachet-Cota, A. L.; Sproviero, E. M.; Ghini, A. A.; Lantos, C. P.; Damasco, M. C. Sodium retaining activity of some natural and synthetic 21-deoxysteroids. Mol. Pharmacol. 1995, 47, 535-543.
5. Galigniana, M. D.; Vicent, G. P.; Piwien-Pilipuk, G.; Burton, G.; Lantos, C. P. Mechanism of action of the potent sodium retaining steroid 11,19-oxidoprogesterone. Mol. Pharmacol. 1998, 58, 58-70.
6. Galigniana, M. D.; Piwien Pilipuk, G.; Kanelakis, K. C.; Burton, G.; Lantos, C. P. Molecular mechanism of activation and nuclear translocation of the mineralocorticoid receptor upon binding of pregnane steroids. Mol. Cell. Endocrinol. 2004, 217, 167-179.
7. Piwien-Pilipuk, G.; Kanelakis, K. C.; Galigniana, M. D. Correlation between pregnanesteroid conformation, receptor affinity, and anti-natriuretic effect. Eur. J. Pharmacol. 2002, 454, 131-143.
8. Vicent, G. P.; Monteserín, M. C.; Veleiro, A. S.; Burton, G.; Lantos, C. P.; Galigniana, M. D. 21-Hydroxy-6, 19-oxidoprogesterone. A novel synthetic steroid with specific antiglucocorticoid properties in the rat. Mol. Pharmacol. 1997, 52, 749-753.
9. Fernández Tresguerres, J., personal communication.
10. Patel, F. A.; Funder, J. W.; Challis, J. R. G. Mechanism of cortisol/progesterone antagonism in the regulation of 15-hydroxyprostaglandin dehydrogenase activity and messenger ribonucleic acid levels in human chorion and placental trophoblast cells at term. J. Clin. Endocrinol. Metab. 2003, 88, 2922-2933.
11. Monteserín, M. C.; Veleiro, A. S.; Burton, G. Photochemically induced oxidation of 6β-sulfanylpregnanes. J. Chem. Res. (S) 1996, 450-451,
12. J. Chem. Res. (M) 1996, 2601-2609.
13. Nicolaou, K. C.; Magolda, R. L.; Sipio, W. J.; Barnette, W. E.; Lysenko, Z.; Joullie, M. M. Phenylselenoetherification. A highly efficient cyclization process for the synthesis of O- and S-heterocycles. J. Am. Chem. Soc. 1980, 102, 3784-3793.
14. Bednarski, J. J.; Porubek, D. J.; Nelson, S. D. Thiol-containing androgens as suicide substrates of aromatase. J. Med. Chem. 1985, 28, 775-779.
15. Nitta, I.; Fujimori, S.; Ueno, H. The syntheses of the corticoid side chain. I. An improved method for the preparation of 17α- hydroxyprogesterone from androst-4-ene-3,17-dione. Bull. Chem. Soc. Jpn. 1985, 58, 978-980.
16. Trost, B. M.; Curran, D. P. Chemoselective oxidation of sulfides to sulfones with potassium hydrogen persulfate. Tetrahedron Lett. 1981, 22, 1287-1291.
17. Amsterdam, A.; Sasson, R. The anti-inflammatory action of glucocorticoids is mediated by cell type specific regulation of apoptosis. Mol. Cell. Endocrinol. 2002, 189, 1-9.
18. Vayssiere, B. M.; Dupont, S.; Choquart, A.; Petit, F.; Garcia, T.; Marchandeau, C.; Gronemeyer, H.; Resche-Rigon, M. Synthetic glucocorticoids that dissociate transactivation and AP-1 transrepression exhibit antiinflammatory activity in vivo. Mol. Endocrinol. 1997, 11, 1245-1255.
19. Wyllie, A. H. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 1980, 284, 555-556.
20. Oldenburg, N. B.; Evans-Storms, J. A.; Cidlowski, J. A. In vivo resistance to glucocorticoid-induced apoptosis in rat thymocytes with normal steroid receptor function in vitro. Endocrinology 1997, 138, 810-818.
21. Compton, M. M.; Cidlowsky, J. A. Vitamin B6 and glucocorticoid action. Endocr. Rev. 1986, 2, 140-148.
22. Fadok, V. A.; Voelker, D. R.; Campbell, P. A.; Cohen, J. J.; Bratton, D. L.; Henson, P. M. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J. Immunol. 1992, 148, 2207-2216.
23. Boersma, A. W. M.; Nooter, K.; Oostrum, R. G.; Stoter, G. Quantification of apoptotic cells with fluorescein isothiocyanate-labeled annexin V in Chinese hamster ovary cell cultures treated with cisplatin. Cytometry 1996, 24, 123-130.
24. van der Burg, B.; van der Saag, T. Nuclear factor-kappa-B/ steroid hormone receptor interactions as a functional basis of anti-inflammatory action of steroids in reproductive organs. Mol. Hum. Reprod. 1996, 2, 433-438.
25. Vicent, G. P.; Pecci, A.; Ghini, A. A.; Piwien-Pilipuk, G.; Veleiro, A. S.; Burton, G.; Lantos, C. P. The glucocorticoid properties of the synthetic steroid pregnan-1,4-diene-11β-ol-3,20-dione (ΔHOP) are not enterely correlated with the steroid binding to the glucocorticoid receptor. Mol. Cell. Endocrinol. 1999, 149, 207-219.
26. S. J. Biol. Chem. 1997, 272, 11791-11798.
27. Hoijman, E.; Rocha Viegas, L.; Keller Sarmiento, M. I.; Rosenstein, R. E.; Pecci, A. Involvement of Bax protein in the prevention of glucocorticoid-induced thymocytes apoptosis by melatonin. Endocrinology 2004, 145, 418-425.
28. Viegas L. R.; Vicent, G. P.; Barañao, J. L.; Beato, M.; Pecci A. Steroid hormones induce bcl-X gene expression through direct activation of distal promoter P4. J. Biol. Chem. 2004, 279, 9831-9839.
29. Wong, T. C.; Rutar, V. Homonuclear Decoupling in Heteronuclear Chemical Shift Correlation Spectroscopy. 1. Study of progesterone. J. Am. Chem. Soc. 1984, 106, 7380-7384.
30. Sheldrick, G. M. SHELXS-97. Program for Structure Resolution, University of Göttingen, Germany, 1997.
31. Sheldrick, G. M. SHELXL-97. Program for Structure Refinement, University of Göttingen, Germany, 1997.
32. Sheldrick, G. M. SHELXTL-PC version 5.0. Siemens Analytical X-ray Instruments, Inc., Madison, WI, 1994.
33. 2] Analogue. J Chem. Soc., Perkin Trans. 1 1983, 2225-2227.
34. Kirk, D. N.; Yeoh B. L. New Syntheses of 19,21-Dihydroxypregn-4-ene-3,20- dione, 21-hydroxy-19-norpregn-4-ene-3,20-dione, and 11β,19,21- trihydroxypregn-4-ene-3,20-dione. J. Chem. Soc., Perkin. Trans. 1 1983, 2945-2951.
35. Herrmann, M.; Lorenz, H. M.; Voll, R.; Gruenke, M.; Woith, W.; Kalden, J. A rapid and simple method for the isolation of apoptotic DNA fragments. Nucleic Acids Res. 1994, 22, 5506-5507.
36. Kastner, P.; Bocquel, M.; Turcotte, B.; Garnier, J.; Horwitz, K.; Chambon, P.; Gronemeyer, H. Transient expression of human and chicken progesterone receptors does not support alternative translational initiation from a single mRNA as the mechanism generating two receptors isoforms. J. Biol. Chem. 1990, 265, 12163-12167.
37. Horwitz, K. B.; Zava, D. T.; Thilagia, A. K.; Jensen, E. M.; McGuire, W. L. Steroid receptor analyses of nine human breast cancer cell lines. Cancer Res. 1978, 38, 2434-2437.